$PNNT

PennantPark Investment Corporation Announces Financial Results for the Third Quarter Ended June 30, 2026

PENNANTPARK INVESTMENT CORP (PNNT) filed an SEC Form 8-K — Results of Operations and Financial Condition. EXHIBIT 99.1 PennantPark Investment Corporation Announces Financial Results for the Third Quarter Ended June 30, 2026 MIAMI, Aug. 10, 2026 (GLOBE NEWSWIRE) -- PennantPark Investment Corporation (NYSE: PNNT) (the "Company") announced today financial results for the third quarter e

Original reporting
Published Aug 10, 2026, 8:05 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 11, 2026, 8:09 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$PNNT
Neutral
medium confidence
Mentioned
$PNNT
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$PNNTNeutralMed
01

Why it matters

Traders can reassess PNNT’s near-term income outlook using reported net investment income, declared distributions, and credit quality (non-accrual count and percentages), while also monitoring NAV per share and unrealized appreciation/depreciation for valuation direction.

02

Market read

The filing updates PNNT’s quarterly earnings, NAV per share, and distribution declarations, plus portfolio credit metrics and activity, which are key inputs for BDC valuation and income positioning.

03

What to watch

The portfolio mix shifted versus Sept. 30, 2025 (higher first-lien secured debt share, lower preferred/common equity share), which could affect future earnings stability and sensitivity to credit spreads and rate resets.

Relevance 7/10Novelty 7/10Timing: after-hours filing on Aug. 10, 2026, ahead of the Aug. 11 conference call

Background

This is an SEC 8-K with an earnings press release for PennantPark Investment Corporation’s third quarter ended June 30, 2026, including portfolio composition, credit quality metrics, and declared distributions.

Company-level read

Ticker impact

$PNNTNeutralMedium confidence
Context

PennantPark Investment Corp reported Q3 ended June 30, 2026 results, including net investment income of $8.9 million and NAV per share of $6.56.

Expected impact

Likely modest price reaction, with focus on NAV per share change (-2.5%), net investment income, and declared distributions ($0.24 total base plus supplemental).

Evidence & confidence

The filing provides concrete quarterly datapoints (NII, NAV, portfolio composition, non-accruals, and distributions) but no explicit guidance change or one-off event beyond the reported quarter.

Market effects

BDC and middle-market credit sentiment may be influenced by reported non-accrual levels (2.5% by cost) and weighted average debt yield (11.0%).

Limited, as the disclosure is company-specific and not a macro release.

Low, since the news is confined to PNNT’s portfolio and quarterly financial condition.

Counterpoint

NAV per share fell 2.5% QoQ, so the income headline (NII $0.14/share) may not fully offset valuation pressure from unrealized depreciation (-$35.0 million).

Key entities

  • PennantPark Investment Corporation

    Reports Q3 ended June 30, 2026 financial results, NAV per share, portfolio composition, and distributions.

  • PennantPark Senior Loan Fund, LLC (PSLF)

    Provides additional portfolio and yield details used in the company’s consolidated highlights.

Related articles

$PNNTMed

PennantPark Investment Corporation Q3 2026 Earnings Call Summary

PennantPark Investment Corp (PNNT) reported Q3 2026 core net investment income of $0.14 per share, above its base dividend. NAV per share fell 2.5% due to supplemental dividend distributions tied to undistributed taxable income. Management cited a 14x gain on a $1.1m defense tech investment, expects JV portfolio growth to about $1.5b, and said JV refinancings add about $0.02/share annually.

$BVSHigh

Bioventus (BVS) Stock Price Slides After Q3 Results Cut Revenue Outlook

Bioventus (BVS) cut its full-year revenue outlook, citing weakness in its BGS product line. Q3 results showed a 5% decline in Global Surgical Solutions revenue and softer International orders, raising concerns about funding growth initiatives. Despite a 20% adjusted EBITDA margin, the stock price fell about 17%. The article also mentions three other undervalued companies but does not provide specific details.

$PPLIMed

People (PPLI) Stock Price Rises Despite Deep Q3 Earnings Loss

People Incorporated (PPLI) reported a deep Q3 earnings loss, with web sessions down 26% and advertising revenue down 8%. Despite this, its stock price rose. Bearish analysts cite risks from AI-driven search changes, privacy constraints, and rising competition. Digital revenue growth slowed to 2%, while non-sessions revenue grew 15% and licensing revenue jumped 49%.